Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer HealthCare submits IND application for BAY-94-9343

June 15, 2011

MLN-4924 has effects in acute myeloid leukemia and high-grade myelodysplastic syndrome

June 15, 2011

Novel anticancer macrocyclic lactones presented

June 15, 2011

KIST researchers prepare new protein kinase inhibitors

June 15, 2011

First-in-human data suggest safety of LY-2090314 in patients with advanced solid tumors

June 15, 2011

Cell Therapeutics meets with FDA to discuss resubmission of pixantrone NDA

June 14, 2011

FDA accepts Adamis Pharmaceuticals' IND for APC-100 for prostate cancer

June 14, 2011

Genosco and Oscotec disclose new protein kinase inhibitors

June 14, 2011

LY-2523355 advances in phase I trial in advanced/metastatic malignancies

June 14, 2011

Drug safety monitoring board recommends advancing DIGNITY to phase II

June 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...